Supplement Monograph

Zinc Oxide

The most zinc-dense but poorest-absorbed oral form — mostly used topically (sunscreen, barrier creams) and in high-dose AREDS eye formulas.

Zinc oxide is the most zinc-dense form (~80% elemental zinc) but the poorest-absorbed of the common oral salts when taken fasting. Its main real-world roles are topical (sunscreens, diaper/barrier creams) and as the high-dose zinc source in the AREDS eye-health formula — not everyday oral supplementation. For zinc’s full evidence base see Zinc; this page covers what’s specific to the oxide form.

Absorption & Tolerability

Zinc oxide is the most zinc-dense oral form — molar mass makes it about 80% elemental zinc by weight — but it is also the least water-soluble of the common salts, and that is the crux of its reputation as “poorly absorbed.” The reality is context-dependent:

  • As a fasting supplement, oxide absorbs less than the soluble salts. In a stable-isotope crossover in 15 healthy adults, fractional zinc absorption from zinc citrate (~61%) and gluconate (~61%) was significantly higher than from zinc oxide (~50%) when each was given as a 10 mg dose without food 1Reference 1Wegmüller et al. · 2014RCTZinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — randomized crossover stable-isotope studyView study →. A 2024 narrative review of the human comparative-absorption literature reaches the same conclusion: the water-soluble forms are the more reliable choice for oral repletion, and oxide is the weak link 2Reference 2Comparative Absorption et al. · 2024ReviewNutrients. https://pubmed.ncbi.nlm.nih.gov/39770891/View study →.
  • In an acidic food matrix, the gap can disappear. When zinc oxide was added as a fortificant to maize/corn tortillas and measured by dual-isotope tracer, fractional absorption did not differ from zinc sulfate 3,4Reference 3Rosado et al. · 2005Zinc absorption from zinc oxide, zinc sulfate, zinc oxide + EDTA, or sodium-zinc EDTA does not differ when added as fortificants to maize tortillas — stable-isotope studyView study →Reference 4Bioavailability of zinc oxide added to c et al. · 2012RCTBioavailability of zinc oxide added to corn tortilla is similar to that of zinc sulfate and is not affected by simultaneous addition of iron (2012) — randomized crossover isotope study. Food and Nutrition Bulletin. https://pubmed.ncbi.nlm.nih.gov/23424892/View study →. Gastric acid dissolves the oxide during digestion, so the “insoluble = unabsorbable” shorthand is too strong once stomach acid and a food meal are involved. (In an achlorhydric or acid-suppressed gut, that advantage is lost — a real-world caveat for older or PPI-treated users.)

Practical read: the one place a clear form-based recommendation holds is oral repletion where absorption matters — prefer a soluble form (citrate, gluconate, bisglycinate) over oxide 1,2Reference 1Wegmüller et al. · 2014RCTZinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — randomized crossover stable-isotope studyView study →Reference 2Comparative Absorption et al. · 2024ReviewNutrients. https://pubmed.ncbi.nlm.nih.gov/39770891/View study →. Oxide’s staying power is economic: it is cheap and zinc-dense, which is why it fills low-cost multivitamins and the high-dose AREDS formula. Gastrointestinally, all oral zinc salts can cause nausea on an empty stomach; oxide is not distinctively better or worse tolerated at matched elemental doses. Topically, zinc oxide is inert and very well tolerated, forming a physical barrier rather than being absorbed 5,6Reference 5Cole et al. · 2010Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen productsView study →Reference 6Pinnell et al. · 1999Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent — comparative studyView study →.

What the Evidence Says

The evidence specific to the oxide form clusters in three non-supplement roles. For zinc’s systemic evidence base (immune function, the common cold, deficiency and repletion), see the Zinc hub — those trials are not form-specific and are not repeated here.

1. High-dose eye health (AREDS). The Age-Related Eye Disease Study used zinc oxide, 80 mg/day elemental, with 2 mg copper, and the original trial found the antioxidant-plus-zinc formulation reduced the ~5-year risk of progression to advanced age-related macular degeneration (AMD) in people at intermediate-to-high risk 7Reference 7Age-Related Eye Disease Study Research G · 2001RCTA randomized, placebo-controlled clinical trial of high-dose vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss — AREDS report noView study →. AREDS2 refined the formula (adding lutein/zeaxanthin, dropping beta-carotene) and, in its dose sub-question, found lowering zinc from 80 mg to 25 mg did not significantly change the benefit — i.e., the 80 mg oxide dose is not clearly necessary 8Reference 8AREDS2 Research Group · 2013RCTLutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration — the AREDS2 randomized clinical trial (includes the 80 mg vs 25 mg zinc sub-randomization)View study →. A 2023 Cochrane review rates the AMD-progression benefit of the antioxidant/mineral formula as moderate-certainty evidence, applicable to people who already have AMD, not to prevention in healthy eyes 9Reference 9Evans et al. · 2023Systematic reviewAntioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration — systematic reviewView study →. The 80 mg dose is twice the adult UL and is an AMD-treatment decision made with a clinician — not a self-selected general supplement.

2. Sunscreen / photoprotection. Zinc oxide is one of only two US-approved actives (with avobenzone) that give true broad-spectrum UVA protection out past 360 nm 5Reference 5Cole et al. · 2010Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen productsView study →, and microfine (“Z-cote”) grades are photostable UVA/UVB blockers that stay transparent on skin 6Reference 6Pinnell et al. · 1999Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent — comparative studyView study →. Multiple reviews and human in-vivo studies find that even nanoparticle zinc oxide does not meaningfully penetrate past the outer stratum corneum — including under occlusion or on barrier-impaired skin — so systemic uptake from sunscreen is negligible 10,11Reference 10Nohynek et al. · 2009ReviewThe safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens — reviewView study →Reference 11Mohammed et al. · 2016Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment — human in-vivo validation studyView study →.

3. Topical barrier and wound care. Zinc oxide paste is a long-standing barrier treatment for diaper dermatitis; small randomized trials support zinc oxide preparations against irritant diaper rash 12Reference 12Efficacy of topical application of eosin et al. · 1999RCTEfficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis (1999) — randomized controlled trial. Dermatology. https://pubmed.ncbi.nlm.nih.gov/10640841/View study →, and zinc-oxide/petrolatum barrier formulations improve skin condition versus no barrier 13Reference 13Skin benefits from continuous topical ad · 2001RCTSkin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper (2001) — randomized controlled trial. JEADV. https://pubmed.ncbi.nlm.nih.gov/11720074/View study →. Zinc’s role in the biochemistry of wound repair (as a cofactor for matrix metalloproteinases and keratinocyte migration) is well described 14Reference 14Lansdown et al. · 2007ReviewZinc in wound healing: theoretical, experimental, and clinical aspects — reviewView study →, though most topical zinc-oxide wound and leg-ulcer use rests on tradition and small studies rather than large modern RCTs.

Bottom line for the form: zinc oxide’s evidence is strongest where it is not absorbed — on the skin (sunscreen, barrier creams) and as the cheap high-dose zinc in AREDS. For everyday oral zinc, a soluble form is the better-absorbed choice.

Dosage

Dosed as elemental zinc; because oxide is ~80% zinc by weight, ~100 mg of zinc oxide supplies ~80 mg elemental zinc. See the Zinc hub for intake references (RDA 8–11 mg/day; UL 40 mg/day for adults, counting supplements, not food).

  • Oral repletion: if using zinc at all for repletion, a soluble form is preferred 1,2Reference 1Wegmüller et al. · 2014RCTZinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — randomized crossover stable-isotope studyView study →Reference 2Comparative Absorption et al. · 2024ReviewNutrients. https://pubmed.ncbi.nlm.nih.gov/39770891/View study →; where oxide is used (multivitamins), take with an acidic meal to aid dissolution and split larger doses (fractional absorption falls as the single dose rises).
  • AREDS eye formula: 80 mg/day elemental zinc (as oxide) with 2 mg copper — 2× the UL, used under medical supervision for existing AMD, not a dose to self-select 7,8Reference 7Age-Related Eye Disease Study Research G · 2001RCTA randomized, placebo-controlled clinical trial of high-dose vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss — AREDS report noView study →Reference 8AREDS2 Research Group · 2013RCTLutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration — the AREDS2 randomized clinical trial (includes the 80 mg vs 25 mg zinc sub-randomization)View study →.
  • Topical: zinc oxide is used at 0.1–40% in creams and pastes; dosing is by product, not systemic intake.

Doses reflect ranges studied in research and are informational, not a personal recommendation.

Safety

General zinc cautions apply and are covered on the Zinc hub; the form-specific points are:

  • Copper depletion is the dose-limiting harm of oral zinc. Sustained intake above the UL (notably the 80 mg AREDS dose) can cause copper deficiency (anemia, neutropenia, myelo-neuropathy) — which is exactly why the AREDS formula includes 2 mg copper 7Reference 7Age-Related Eye Disease Study Research G · 2001RCTA randomized, placebo-controlled clinical trial of high-dose vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss — AREDS report noView study →. Do not run high-dose oxide without matching copper.
  • Absorption interactions: zinc competes with copper and iron for absorption, and separates in time from tetracycline/fluoroquinolone antibiotics (space ≥2 h). Poor fasting solubility does not exempt oxide from these interactions once dissolved.
  • Topical zinc oxide is one of the best-tolerated dermatologic agents; contact allergy is rare. Sunscreen safety: human and review data show negligible dermal penetration of even nanoparticle ZnO, so systemic exposure from topical use is minimal 10,11Reference 10Nohynek et al. · 2009ReviewThe safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens — reviewView study →Reference 11Mohammed et al. · 2016Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment — human in-vivo validation studyView study →.
  • Inhalation is a separate hazard unrelated to supplement use: inhaling zinc oxide fume (welding/galvanizing) causes metal-fume fever. Not relevant to oral or topical consumer products, but worth naming.

Pregnancy & lactation

Topical zinc oxide (barrier creams, sunscreen) is considered low-risk in pregnancy and lactation given its negligible absorption. High-dose oral zinc (the AREDS 80 mg regimen) is not a pregnancy indication and should not be self-selected. This form page does not add an oral-zinc pregnancy assessment beyond the hub; see Zinc for oral-zinc pregnancy detail.

References

  1. Wegmüller, R., Tay, F., Zeder, C., Brnić, M., Hurrell, R. F. (2014). Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — randomized crossover stable-isotope study. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/24259556/
  2. Comparative Absorption and Bioavailability of Various Chemical Forms of Zinc in Humans: A Narrative Review (2024). Nutrients. https://pubmed.ncbi.nlm.nih.gov/39770891/
  3. Rosado, J. L., et al. (2005). Zinc absorption from zinc oxide, zinc sulfate, zinc oxide + EDTA, or sodium-zinc EDTA does not differ when added as fortificants to maize tortillas — stable-isotope study. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/15867288/
  4. Bioavailability of zinc oxide added to corn tortilla is similar to that of zinc sulfate and is not affected by simultaneous addition of iron (2012) — randomized crossover isotope study. Food and Nutrition Bulletin. https://pubmed.ncbi.nlm.nih.gov/23424892/
  5. Cole, C., et al. (2010). Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products. American Journal of Clinical Dermatology. https://pubmed.ncbi.nlm.nih.gov/20806994/
  6. Pinnell, S. R., et al. (1999). Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent — comparative study. Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/9922017/
  7. Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled clinical trial of high-dose vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss — AREDS report no. 8. Archives of Ophthalmology. https://pubmed.ncbi.nlm.nih.gov/11594942/
  8. AREDS2 Research Group (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration — the AREDS2 randomized clinical trial (includes the 80 mg vs 25 mg zinc sub-randomization). JAMA. https://pubmed.ncbi.nlm.nih.gov/23644932/
  9. Evans, J. R., Lawrenson, J. G. (2023). Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration — systematic review. Cochrane Database of Systematic Reviews. https://pubmed.ncbi.nlm.nih.gov/37702300/
  10. Nohynek, G. J., et al. (2009). The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens — review. Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/19646780/
  11. Mohammed, Y. H., et al. (2016). Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment — human in-vivo validation study. European Journal of Pharmaceutics and Biopharmaceutics. https://pubmed.ncbi.nlm.nih.gov/27131753/
  12. Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis (1999) — randomized controlled trial. Dermatology. https://pubmed.ncbi.nlm.nih.gov/10640841/
  13. Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper (2001) — randomized controlled trial. JEADV. https://pubmed.ncbi.nlm.nih.gov/11720074/
  14. Lansdown, A. B., et al. (2007). Zinc in wound healing: theoretical, experimental, and clinical aspects — review. Wound Repair and Regeneration. https://pubmed.ncbi.nlm.nih.gov/17244314/